Kent Hoskins, MD
Associate Professor of Medicine
Dr. Kent Hoskins is an associate professor of medicine in the Division of Hematology/Oncology in the Department of Medicine in the College of Medicine and an Institute for Health Research and Policy (IHRP) Fellow at the University of Illinois at Chicago. He directs the UIC Familial Breast Cancer Program.
Dr. Hoskins is board certified in internal medicine with a sub-specialty in medical oncology. He earned his medical degree and completed his internship and residency at the University of Iowa. He completed fellowships in hematology and oncology as well as postdoctoral research in cancer genetics at the University of Michigan.
Recent and Noteworthy Publications
Dabbous FM, Dolecek TA, Berbaum ML, Friedewald SM, Summerfelt WT, Hoskins K, Rauscher GH. Impact of a False-Positive Screening Mammogram on Subsequent Screening Behavior and Stage at Breast Cancer Diagnosis. Cancer Epidemiol Biomarkers Prev. 2017 Feb 9. [Epub ahead of print]. [See abstract.]
Anderson EE, Tejeda S, Childers K, Stolley MR, Warnecke RB, Hoskins KF. Cancer risk assessment among low-income women of color in primary care: a pilot study. J Oncol Pract. 2015 Jul;11(4):e460-7. [See abstract.]
Brewer KC, Peterson CE, Davis FG, Hoskins K, Pauls H, Joslin CE. The influence of neighborhood socioeconomic status and race on survival from ovarian cancer: a population-based analysis of Cook County, Illinois. Ann Epidemiol. 2015 Aug;25(8):556-63. [See abstract.]
Mortel M, Rauscher GH, Murphy AM, Hoskins K, Warnecke RB. Racial and ethnic disparity in symptomatic breast cancer awareness despite a recent screen: the role of tumor biology and mammography facility characteristics. Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1599-606. [See abstract.]
Sheean P, Kabir C, Rao R, Hoskins K, Stolley M. Exploring diet, physical activity and quality of life in females with metastatic breast cancer: a pilot study to support future intervention. J Acad Nutr Diet. 2015 Oct;115(10):1690-8. [See abstract.]
Joslin CE, Brewer KC, Davis FG, Hoskins K, Peterson CE, Pauls HA. The effect of neighborhood-level socioeconomic status on racial differences in ovarian cancer treatment in a population-based analysis in Chicago. Gynecol Oncol. 2014 Aug 27. [See abstract.]
Silva A, Rauscher GH, Ferrans CE, Hoskins K, Rao R. Assessing the quality of race/ethnicity, tumor, and breast cancer treatment information in a non-SEER state registry. J Registry Manag. 2014 Spring;41(1):24-30. [See abstract.]
Jackson SA, Davis AA, Li J, Yi N, et al. Northwestern Cancer Genetics Group. Characteristics of individuals with breast cancer rearrangements in BRCA1 and BRCA2. Cancer. 2014 May 15;120(10):1557-64.
Silva A, Rauscher GH, Hoskins K, Rao R, Ferrans CE. Assessing racial/ethnic disparities in chemotherapy treatment among breast cancer patients in context of changing treatment guidelines. Breast Cancer Res Treat. 2013 Dec;142(3):667-72.
Anderson EE, Hoskins K. Individual breast cancer risk assessment in underserved populations: integrating empirical bioethics and health disparities research. J Health Care Poor Underserved. 2012 Nov;23(4 Suppl):34-46. [See abstract.]
Sheean PM, Hoskins K, Stolley M. Body composition changes in females treated for breast cancer: a review of the evidence. Breast Cancer Res Treat. 2012 Oct;135(3):663-80. [See abstract.]
Teller P, Hoskins KF, Zwaagstra A, Stanislaw C, Iyengar R, Green VL, Gabram SG. Validation of the pedigree assessment tool (PAT) in families with BRCA1 and BRCA2 mutations. Ann Surg Oncol. 2010 Jan;17(1):240-246.
Hoskins KF, Zwaagstra A, Ranz M. Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening. Cancer. 2006 Oct 15;107(8):1769-1776.
Honors and Awards